On April 30, 2025, Autonomix Medical, Inc. announced positive results from its trial involving 20 patients with severe pancreatic cancer pain, marking a step towards a market expansion study for visceral cancer pain.
AI Assistant
AUTONOMIX MEDICAL INC
2025
8 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.